血管紧张素II受体阻滞剂：ACE抑制剂的等效替代物还是首选替代物？ - Suppr

Suppr

超能文献

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

作者信息

Grossman E, Messerli F H, Neutel J M

机构信息

Internal Medicine D, The Chaim Sheba Medical Center, Sackler School of Medicine, Tel-Hashomer 52621, Israel.

出版信息

Arch Intern Med. 2000 Jul 10;160(13):1905-11. doi: 10.1001/archinte.160.13.1905.

DOI:10.1001/archinte.160.13.1905

PMID:10888965

Abstract

摘要

相似文献

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

Arch Intern Med. 2000 Jul 10;160(13):1905-11. doi: 10.1001/archinte.160.13.1905.

Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.

J Cardiovasc Pharmacol. 2001 Jul;38(1):141-8. doi: 10.1097/00005344-200107000-00015.

[Theoretical background of angiotensin II receptor blockade and its features in clinical pharmacology].

Orv Hetil. 2003 Sep 7;144(36):1763-8.

[Irbesartan: a new possibility in the treatment of hypertension].

Orv Hetil. 2002 May 26;143(21):1187-92.

Angiotensin-II receptor antagonists: their place in therapy.

Am Fam Physician. 1999 Jun;59(11):3140-8.

Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.

J Hypertens. 2001 Mar;19(3):465-73. doi: 10.1097/00004872-200103000-00015.

Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.

J Med Chem. 2003 Jun 5;46(12):2261-70. doi: 10.1021/jm0204237.

Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications.

Postgrad Med. 2001 Apr;109(4):115-22; quiz 9. doi: 10.3810/pgm.2001.04.911.

Angiotensin II type 1 receptor blockers.

Circulation. 2001 Feb 13;103(6):904-12. doi: 10.1161/01.cir.103.6.904.

Angiotensin receptor antagonists.

Aust Fam Physician. 2000 Jul;29(7):653-5, 658.

引用本文的文献

Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis.

Cureus. 2023 Oct 30;15(10):e47954. doi: 10.7759/cureus.47954. eCollection 2023 Oct.

Sitagliptin-associated angioedema.

Diabetes Care. 2012 Aug;35(8):e60. doi: 10.2337/dc12-0574.

Long-term use and tolerability of irbesartan for control of hypertension.

Integr Blood Press Control. 2011;4:17-26. doi: 10.2147/IBPC.S12211. Epub 2011 Apr 18.

Angioedema: clinical and etiological aspects.

Clin Dev Immunol. 2007;2007:26438. doi: 10.1155/2007/26438.

Angiotensin inhibition after myocardial infarction: does drug class matter?

J Gen Intern Med. 2006 Dec;21(12):1242-7. doi: 10.1111/j.1525-1497.2006.00590.x.

Angioedema induced by tramadol--a potentially life-threatening condition.

Eur J Clin Pharmacol. 2005 Feb;60(12):901-3. doi: 10.1007/s00228-004-0882-5. Epub 2005 Jan 19.

Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough.

J Gen Intern Med. 2004 Jun;19(6):684-91. doi: 10.1111/j.1525-1497.2004.30016.x.

Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reduction.

J Clin Hypertens (Greenwich). 2004 Jun;6(6):315-23; quiz 324-5. doi: 10.1111/j.1524-6175.2006.03473.x.

Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy.

Clin Cardiol. 2002 May;25(5):205-12. doi: 10.1002/clc.4950250503.

Drug-induced angioedema without urticaria.

Drug Saf. 2001;24(8):599-606. doi: 10.2165/00002018-200124080-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

作者信息

Grossman E, Messerli F H, Neutel J M

机构信息

Internal Medicine D, The Chaim Sheba Medical Center, Sackler School of Medicine, Tel-Hashomer 52621, Israel.

出版信息

Arch Intern Med. 2000 Jul 10;160(13):1905-11. doi: 10.1001/archinte.160.13.1905.

DOI:10.1001/archinte.160.13.1905

PMID:10888965

Abstract

摘要

相似文献

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

Arch Intern Med. 2000 Jul 10;160(13):1905-11. doi: 10.1001/archinte.160.13.1905.

Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.

J Cardiovasc Pharmacol. 2001 Jul;38(1):141-8. doi: 10.1097/00005344-200107000-00015.

[Theoretical background of angiotensin II receptor blockade and its features in clinical pharmacology].

Orv Hetil. 2003 Sep 7;144(36):1763-8.

[Irbesartan: a new possibility in the treatment of hypertension].

Orv Hetil. 2002 May 26;143(21):1187-92.

Angiotensin-II receptor antagonists: their place in therapy.

Am Fam Physician. 1999 Jun;59(11):3140-8.

Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.

J Hypertens. 2001 Mar;19(3):465-73. doi: 10.1097/00004872-200103000-00015.

Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.

J Med Chem. 2003 Jun 5;46(12):2261-70. doi: 10.1021/jm0204237.

Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications.

Postgrad Med. 2001 Apr;109(4):115-22; quiz 9. doi: 10.3810/pgm.2001.04.911.

Angiotensin II type 1 receptor blockers.

Circulation. 2001 Feb 13;103(6):904-12. doi: 10.1161/01.cir.103.6.904.

Angiotensin receptor antagonists.

Aust Fam Physician. 2000 Jul;29(7):653-5, 658.

引用本文的文献

Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis.

Cureus. 2023 Oct 30;15(10):e47954. doi: 10.7759/cureus.47954. eCollection 2023 Oct.

Sitagliptin-associated angioedema.

Diabetes Care. 2012 Aug;35(8):e60. doi: 10.2337/dc12-0574.

Long-term use and tolerability of irbesartan for control of hypertension.

Integr Blood Press Control. 2011;4:17-26. doi: 10.2147/IBPC.S12211. Epub 2011 Apr 18.

Angioedema: clinical and etiological aspects.

Clin Dev Immunol. 2007;2007:26438. doi: 10.1155/2007/26438.

Angiotensin inhibition after myocardial infarction: does drug class matter?

J Gen Intern Med. 2006 Dec;21(12):1242-7. doi: 10.1111/j.1525-1497.2006.00590.x.

Angioedema induced by tramadol--a potentially life-threatening condition.

Eur J Clin Pharmacol. 2005 Feb;60(12):901-3. doi: 10.1007/s00228-004-0882-5. Epub 2005 Jan 19.

Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough.

J Gen Intern Med. 2004 Jun;19(6):684-91. doi: 10.1111/j.1525-1497.2004.30016.x.

Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reduction.

J Clin Hypertens (Greenwich). 2004 Jun;6(6):315-23; quiz 324-5. doi: 10.1111/j.1524-6175.2006.03473.x.

Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy.

Clin Cardiol. 2002 May;25(5):205-12. doi: 10.1002/clc.4950250503.

Drug-induced angioedema without urticaria.

Drug Saf. 2001;24(8):599-606. doi: 10.2165/00002018-200124080-00004.